Drug Profile
Cryptococcus neoformans vaccine - Albert Einstein College of Medicine
Alternative Names: GXM-BSA; GXM-TT; P13-BSA; P13-TTLatest Information Update: 12 Dec 2003
Price :
$50
*
At a glance
- Originator Albert Einstein College of Medicine
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cryptococcosis
Most Recent Events
- 12 Dec 2003 No development reported - Preclinical for Cryptococcosis in USA (unspecified route)
- 16 Jul 2001 This compound is still in active development
- 16 Jul 2001 Preclinical development for Cryptococcosis in USA (Unknown route)